About a year ago, the head of a cannabis company approached genetic technology expert John Lem with a problem; why did he have an adverse reaction from pot when everyone else who had smoked the same joint seemed fine?
So Lem set out to find whether there was a genetic explanation for the different ways people react to THC, and that’s how his Toronto-based company Lobo Genetics was born.
Through a simple cheek swab, Lobo Genetics examines three genes to see how your body interacts with THC. Lem says, the genes reveal how you metabolize the drug, whether you’re prone to memory loss, and if you have an increased risk of paranoia while you’re high, or a long term risk of developing schizophrenia.
“Looking into the science, we came to the conclusion that there is actually a genetic basis for someone’s reaction to THC,” said Lem.